Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Control Drug Delivery System

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 24

Drug delivery system

Controlled release system

R. Venkatesh M pharm(Pceutics), TKR COLLEGE OF PHARMACY, MEERPET, HYD

Sustained drug delivery system


Simply prolong the drug release Plasma drug level for extended period of time Not necessarily at predetermined time rate Reduce dosing frequency Uniform plasma concentration at steady state.

Controlled drug delivery system


Prolonged release, Delivers the drug at predetermined rate, locally or systemically for specified period of time.

Pharmaceutical dosage forms for systemic administration


Generations of dosage forms 1st gen. conventional (unmodified) release of API 2nd gen. controlled release of API (CR) 3rd gen. targeted distribution drug delivery systems

Conventional vs. Controlled release dosage forms


I. Gen. disintegration (p desegregation) of the dosage form and dissolution of is spontaneous process;
drug absorption and distribution is based only on physico-chemical properties.

II. Gen. The release is under control of the drug delivery system Advantages:
Avoids fluctuations of plasma drug concentration p better safety and efficacy Decreased frequency of drug administration (often once daily admin) p better compliance May overcome some problems with BAV Can be much more economical (better cost-effectiveness)

Sustained release (SR) release of the initial API dose & further prolonged release

Controlled release (CR) properly controlled (0. order) release

Biopharmaceutical consideration
1. Release from formulation 2. Movement within body during its passage to site of action
Drug in dosage form
Release

Drug at the absorption site

Rate limiting step of controlled release

Absorption
Drug in body

Rate limiting step of conventional release

Biopharmaceutical properties
Molecular weight of drug Aqueous solubility of the drug Apparent partition coefficient of drug Drug pKa and pH Drug stability in G.I.T. Mechanism of absorption Route of administration

Pharmacokinetic characteristics of drug


Absorption rate Elimination half-life Rate of metabolism Dosage form index (DI), (plasma peak-valley ratio i.e. Css.max to Css.min.)

Pharmacodynamic characteristics of drug


Therapeutic range Therapeutic index Plasma concentration- Response relationship

Drug release patterns


Drug disposition fallows first order kinetics Rate limiting step is in the absorptions rate of drug release Drug release rapidly and completely absorbed

Approaches
A. Continuous release system
1. Dissolution Controlled drug release system a. Matrix Dissolution Controlled system b. Encapsulation/coating Dissolution Controlled drug release system 2. Diffusion Controlled drug release system a. Matrix Diffusion system b. Reservoir devices 3. Dissolution and diffusion Controlled drug release system 4. 5. 6. 7. 8. Ion exchange resin drug complexes Slow dissolving salts and complexes pH depending formulation Osmotic pressure Controlled system Hydrodynamic pressure Controlled system

Dosage forms for systemic administration Parenteral route dosage forms Implants
Controlled drug delivery for over a long time (months/years) Principle Reservoir (Osmotic/diffusion) systems Matrix systems
Non-biodegradable Biodegrable polymeric materials with dispersed drug

Advantages largely overcomes problems with individual compliance Disadvantages mini-surgery is needed, uneasy to simply discontinue the therapy, local reactions

Examples: hormones/contraception

Dosage forms for systemic administration


Transdermal drug delivery sytems (TDDS)
Advantages
Elegant alternative to injectables Pain and stress-free No need for trained specialist Long-term drug delivery with minimal fluctuations of drug concentrations Good compliance Unlike other controlled drug delivery systems, the delivery of the API can be immediately discontinued (e.g., upon occurrence of adverse reactions)

Disadvantages
Not feasible for all API ! Mr < 500 Well balanced lipohilicity High potency (high doses can not be accommodated and delivered) p Penetration enhancers can help! Local relations (irritation, disruption of barrier skin function) Need not be practical/comfortable Need not be cost-effective

Examples of clinical use: hormones (HRT, contraceptives), opioid analgesics (e.g., fentanyl), nitroglycerine, nicotine (RT), clonidine or scopolamine

Delayed transit and continuous release system


1. Altered density system a. high density pellets b. low density pellets 2. Mucoadhesive system 3. Size based system

Delayed release system


1. Intestinal release system 2. Colonic release system

Parenteral Controlled release system


A.Injectabales 1. Solutions 2. Dispersions 3. Microsphers and microcapsules 4. Nanoparticals and niosomes 5. Liposomes 6. Resealed erythrocytes B. Implants devices 1. Osmotic pumps 2. Vapor pressure powered pumps 3. Battery power pumps

Transdermal drug delivery system


1. Matrix 2. Reservoir 3. Mixed Reservoir

Ophthalmic drug delivery system


Inserts or ocuserts

Intravaginal and intrauterine drug delivery system

Liposome's

Niosomes

Evaluation testing

In vitro measurements of drug availability In vivo measurements of drug availability

Thank you for your attention

You might also like